Epstein-barr virus sequence variation-biology and disease

Pathogens

Volumn 1, Issue 2, 2012, Pages 156-175

  Tzellos, Stelios ^a   Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Epstein barr virus; Sequence variation; Virus types

Indexed keywords

CHEMOKINE RECEPTOR CXCR7; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CELL PROLIFERATION; CELL SURVIVAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; IMMUNOSURVEILLANCE; LARGE CELL LYMPHOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; VIRUS CELL TRANSFORMATION; VIRUS GENOME; VIRUS RECOMBINATION; VIRUS REPLICATION;

EID: 84888231919     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens1020156     Document Type: Review

References (147)

1. Rickinson, A.; Kieff, E. Epstein-Barr Virus. In Fields Virology, Fifth ed.; Knipe, D., Howley, P., Eds.; Lippincott, Williams and Wilkins: Philadelphia, PA, USA, 2007; pp. 2655-2700.
2. Jenkins, P.J.; Farrell, P.J. Are particular Epstein-Barr virus strains linked to disease? Semin. Cancer Biol. 1996, 7, 209-215.
3. White, R.E.; Ramer, P.C.; Naresh, K.N.; Meixlsperger, S.; Pinaud, L.; Rooney, C.; Savoldo, B.; Coutinho, R.; Bodor, C.; Gribben, J., et al. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J. Clin. Invest. 2012, 122, 1487-1502.
4. Cheung, A.; Kieff, E. Long internal direct repeat in Epstein-Barr virus DNA. J. Virol. 1982, 44, 286-294.
5. Dambaugh, T.R.; Kieff, E. Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA. J. Virol. 1982, 44, 823-833.
6. Baer, R.; Bankier, A.T.; Biggin, M.D.; Deininger, P.L.; Farrell, P.J.; Gibson, T.J.; Hatfull, G.; Hudson, G.S.; Satchwell, S.C.; Seguin, C., et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984, 310, 207-211.
7. Miller, G.; Shope, T.; Lisco, H.; Stitt, D.; Lipman, M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA 1972, 69, 383-387.
8. Arrand, J.R.; Rymo, L.; Walsh, J.E.; Bjorck, E.; Lindahl, T.; Griffin, B.E. Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res. 1981, 9, 2999-3014.
9. Raab-Traub, N.; Dambaugh, T.; Kieff, E. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 1980, 22, 257-267.
10. Parker, B.D.; Bankier, A.; Satchwell, S.; Barrell, B.; Farrell, P.J. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 1990, 179, 339-346.
11. de Jesus, O.; Smith, P.R.; Spender, L.C.; Elgueta Karstegl, C.; Niller, H.H.; Huang, D.; Farrell, P.J. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 2003, 84, 1443-1450.
12. Fruscalzo, A.; Marsili, G.; Busiello, V.; Bertolini, L.; Frezza, D. DNA sequence heterogeneity within the Epstein-Barr virus family of repeats in the latent origin of replication. Gene 2001, 265, 165-173.
13. Kanda, T.; Shibata, S.; Saito, S.; Murata, T.; Isomura, H.; Yoshiyama, H.; Takada, K.; Tsurumi, T. Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems. PLoS One 2011, 6, e27758.
14. Dolan, A.; Addison, C.; Gatherer, D.; Davison, A.J.; McGeoch, D.J. The genome of Epstein-Barr virus type 2 strain AG876. Virology 2006, 350, 164-170.
15. Zeng, M.S.; Li, D.J.; Liu, Q.L.; Song, L.B.; Li, M.Z.; Zhang, R.H.; Yu, X.J.; Wang, H.M.; Ernberg, I.; Zeng, Y.X. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J. Virol. 2005, 79, 15323-15330.
16. Liu, P.; Fang, X.; Feng, Z.; Guo, Y.M.; Peng, R.J.; Liu, T.; Huang, Z.; Feng, Y.; Sun, X.; Xiong, Z., et al. Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J. Virol. 2011, 85, 11291-11299.
17. Kwok, H.; Tong, A.H.; Lin, C.H.; Lok, S.; Farrell, P.J.; Kwong, D.L.; Chiang, A.K. Genomic sequencing and comparative analysis of epstein-barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS One 2012, 7, e36939.
18. Dambaugh, T.; Hennessy, K.; Chamnankit, L.; Kieff, E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 1984, 81, 7632-7636.
19. Adldinger, H.K.; Delius, H.; Freese, U.K.; Clarke, J.; Bornkamm, G.W. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 1985, 141, 221-234.
20. Rowe, M.; Young, L.S.; Cadwallader, K.; Petti, L.; Kieff, E.; Rickinson, A.B. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J. Virol. 1989, 63, 1031-1039.
21. Rickinson, A.B.; Young, L.S.; Rowe, M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 1987, 61, 1310-1317.
22. Midgley, R.S.; Blake, N.W.; Yao, Q.Y.; Croom-Carter, D.; Cheung, S.T.; Leung, S.F.; Chan, A.T.; Johnson, P.J.; Huang, D.; Rickinson, A.B., et al. Novel intertypic recombinants of epstein-barr virus in the chinese population. J. Virol. 2000, 74, 1544-1548.
23. Yao, Q.Y.; Tierney, R.J.; Croom-Carter, D.; Cooper, G.M.; Ellis, C.J.; Rowe, M.; Rickinson, A.B. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J. Virol. 1996, 70, 4895-4903.
24. Kim, S.M.; Kang, S.H.; Lee, W.K. Identification of two types of naturally-occurring intertypic recombinants of Epstein-Barr virus. Mol. Cells 2006, 21, 302-307.
25. McGeoch, D.J.; Gatherer, D. Lineage structures in the genome sequences of three Epstein-Barr virus strains. Virology 2007, 359, 1-5.
26. Schuster, V.; Ott, G.; Seidenspinner, S.; Kreth, H.W. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 1996, 87, 1579-1585.
27. Suspene, R.; Aynaud, M.M.; Koch, S.; Pasdeloup, D.; Labetoulle, M.; Gaertner, B.; Vartanian, J.P.; Meyerhans, A.; Wain-Hobson, S. Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol. 2011, 85, 7594-7602.
28. Burrows, J.M.; Bromham, L.; Woolfit, M.; Piganeau, G.; Tellam, J.; Connolly, G.; Webb, N.; Poulsen, L.; Cooper, L.; Burrows, S.R., et al. Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia. J. Virol. 2004, 78, 7131-7137.
29. Midgley, R.S.; Bell, A.I.; McGeoch, D.J.; Rickinson, A.B. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J. Virol. 2003, 77, 11517-11530.
30. Midgley, R.S.; Bell, A.I.; Yao, Q.Y.; Croom-Carter, D.; Hislop, A.D.; Whitney, B.M.; Chan, A.T.; Johnson, P.J.; Rickinson, A.B. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. J. Virol. 2003, 77, 11507-11516.
31. Nagamine, M.; Kishibe, K.; Takahara, M.; Nagato, T.; Ishii, H.; Bandoh, N.; Ogino, T.; Harabuchi, Y. Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients. Intervirology 2007, 50, 319-322.
32. Tang, Y.L.; Lu, J.H.; Cao, L.; Wu, M.H.; Peng, S.P.; Zhou, H.D.; Huang, C.; Yang, Y.X.; Zhou, Y.H.; Chen, Q., et al. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz. J. Med. Biol. Res. 2008, 41, 110-116.
33. Lin, J.C.; Cherng, J.M.; Lin, H.J.; Tsang, C.W.; Liu, Y.X.; Lee, S.P. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'. J. Gen. Virol. 2004, 85, 2023-2034.
34. Lin, H.J.; Cherng, J.M.; Hung, M.S.; Sayion, Y.; Lin, J.C. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan. J. Biomed. Sci. 2005, 12, 925-936.
35. Duraiswamy, J.; Burrows, J.M.; Bharadwaj, M.; Burrows, S.R.; Cooper, L.; Pimtanothai, N.; Khanna, R. Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. J. Virol. 2003, 77, 7401-7410.
36. Kelly, G.; Bell, A.; Rickinson, A. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 2002, 8, 1098-1104.
37. Kelly, G.L.; Long, H.M.; Stylianou, J.; Thomas, W.A.; Leese, A.; Bell, A.I.; Bornkamm, G.W.; Mautner, J.; Rickinson, A.B.; Rowe, M. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog. 2009, 5, e1000341.
38. Hatfull, G.; Bankier, A.T.; Barrell, B.G.; Farrell, P.J. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 1988, 164, 334-340.
39. Decaussin, G.; Leclerc, V.; Ooka, T. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. J. Virol. 1995, 69, 7309-7314.
40. Jenson, H.B.; Rabson, M.S.; Miller, G. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA. J. Virol. 1986, 58, 475-486.
41. Rooney, C.; Taylor, N.; Countryman, J.; Jenson, H.; Kolman, J.; Miller, G. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc. Natl. Acad. Sci. USA 1988, 85, 9801-9805.
42. Patton, D.F.; Shirley, P.; Raab-Traub, N.; Resnick, L.; Sixbey, J.W. Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia. J. Virol. 1990, 64, 397-400.
43. Gan, Y.J.; Razzouk, B.I.; Su, T.; Sixbey, J.W. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Am. J. Pathol. 2002, 160, 781-786.
44. Ryan, J.L.; Jones, R.J.; Elmore, S.H.; Kenney, S.C.; Miller, G.; Schroeder, J.C.; Gulley, M.L. Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo. Intervirology 2009, 52, 8-16.
45. Mainou, B.A.; Raab-Traub, N. LMP1 strain variants: biological and molecular properties. J. Virol. 2006, 80, 6458-6468.
46. Miller, W.E.; Edwards, R.H.; Walling, D.M.; Raab-Traub, N. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 1994, 75(Pt 10), 2729-2740.
47. Walling, D.M.; Etienne, W.; Ray, A.J.; Flaitz, C.M.; Nichols, C.M. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia. J. Infect. Dis. 2004, 190, 387-395.
48. Sung, N.S.; Edwards, R.H.; Seillier-Moiseiwitsch, F.; Perkins, A.G.; Zeng, Y.; Raab-Traub, N. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int. J. Cancer 1998, 76, 207-215.
49. Kanai, K.; Satoh, Y.; Saiki, Y.; Ohtani, H.; Sairenji, T. Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1. Virus Genes 2007, 34, 55-61.
50. Nagamine, M.; Takahara, M.; Kishibe, K.; Nagato, T.; Ishii, H.; Bandoh, N.; Ogino, T.; Harabuchi, Y. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes 2007, 34, 47-54.
51. Lin, S.X.; Zong, Y.S.; Zhang, M.; Han, A.J.; Zhong, B.L.; Liang, Y.J. Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma. Zhonghua Bing Li Xue Za Zhi 2005, 34, 791-795.
52. Zhao, S.; Liu, W.P.; Wang, X.L.; Zhang, W.Y.; Jiang, W.; Tang, Y.; Li, G.D. Detection of the 30 base pair deletion of Epstein-Barr virus latent membrane protein 1 in extranodal nasal type NK/T-cell lymphoma and its prognostic significance. Zhonghua Bing Li Xue Za Zhi 2005, 34, 720-723.
53. Shibata, Y.; Hoshino, Y.; Hara, S.; Yagasaki, H.; Kojima, S.; Nishiyama, Y.; Morishima, T.; Kimura, H. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. J. Med. Virol. 2006, 78, 770-779.
54. Saechan, V.; Mori, A.; Mitarnun, W.; Settheetham-Ishida, W.; Ishida, T. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity. J. Clin. Virol. 2006, 36, 119-125.
55. Dardari, R.; Khyatti, M.; Cordeiro, P.; Odda, M.; ElGueddari, B.; Hassar, M.; Menezes, J. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients. Int. J. Cancer 2006, 118, 1977-1983.
56. Li, D.J.; Bei, J.X.; Mai, S.J.; Xu, J.F.; Chen, L.Z.; Zhang, R.H.; Yu, X.J.; Hong, M.H.; Zeng, Y.X.; Kang, T. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma. J. Med. Virol. 2009, 81, 1253-1260.
57. Saechan, V.; Settheetham-Ishida, W.; Kimura, R.; Tiwawech, D.; Mitarnun, W.; Ishida, T. Epstein-Barr virus strains defined by the latent membrane protein 1 sequence characterize Thai ethnic groups. J. Gen. Virol. 2010, 91, 2054-2061.
58. Nguyen-Van, D.; Ernberg, I.; Phan-Thi Phi, P.; Tran-Thi, C.; Hu, L. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. Virus Genes 2008, 37, 273-281.
59. Pavlish, O.A.; Diduk, S.V.; Smirnova, K.V.; Shcherbak, L.N.; Goncharova, E.V.; Shalginskikh, N.A.; Arkhipov, V.V.; Kichigina, M.; Stepina, V.N.; Belousova, N.V., et al. [Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals]. Vopr. Virusol. 2008, 53, 10-16.
60. Wang, Y.; Kanai, K.; Satoh, Y.; Luo, B.; Sairenji, T. Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan. Intervirology 2007, 50, 229-236.
61. Zuercher, E.; Butticaz, C.; Wyniger, J.; Martinez, R.; Battegay, M.; Boffi El Amari, E.; Dang, T.; Egger, J.F.; Fehr, J.; Mueller-Garamvogyi, E., et al. Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Kappab activation. PLoS One 2012, 7, e32168.
62. Edwards, R.H.; Sitki-Green, D.; Moore, D.T.; Raab-Traub, N. Potential selection of LMP1 variants in nasopharyngeal carcinoma. J. Virol. 2004, 78, 868-881.
63. Tierney, R.J.; Edwards, R.H.; Sitki-Green, D.; Croom-Carter, D.; Roy, S.; Yao, Q.Y.; Raab-Traub, N.; Rickinson, A.B. Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J. Infect. Dis. 2006, 193, 287-297.
64. Fafi-Kremer, S.; Morand, P.; Germi, R.; Ballout, M.; Brion, J.P.; Genoulaz, O.; Nicod, S.; Stahl, J.P.; Ruigrok, R.W.; Seigneurin, J.M. A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. J. Infect. Dis. 2005, 192, 2108-2111.
65. Rey, J.; Xerri, L.; Bouabdallah, R.; Keuppens, M.; Brousset, P.; Meggetto, F. Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient. Br. J. Haematol. 2008, 142, 79-81.
66. Palefsky, J.M.; Berline, J.; Greenspan, D.; Greenspan, J.S. Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes. J. Gen. Virol. 2002, 83, 317-321.
67. Walling, D.M.; Brown, A.L.; Etienne, W.; Keitel, W.A.; Ling, P.D. Multiple Epstein-Barr virus infections in healthy individuals. J. Virol. 2003, 77, 6546-6550.
68. Sitki-Green, D.; Covington, M.; Raab-Traub, N. Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers. J. Virol. 2003, 77, 1840-1847.
69. Sitki-Green, D.; Edwards, R.H.; Webster-Cyriaque, J.; Raab-Traub, N. Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay. J. Virol. 2002, 76, 9645-9656.
70. Sitki-Green, D.L.; Edwards, R.H.; Covington, M.M.; Raab-Traub, N. Biology of Epstein-Barr virus during infectious mononucleosis. J. Infect. Dis. 2004, 189, 483-492.
71. Hu, L.F.; Zabarovsky, E.R.; Chen, F.; Cao, S.L.; Ernberg, I.; Klein, G.; Winberg, G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 1991, 72(Pt 10), 2399-2409.
72. Hu, L.F.; Chen, F.; Zheng, X.; Ernberg, I.; Cao, S.L.; Christensson, B.; Klein, G.; Winberg, G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993, 8, 1575-1583.
73. Huen, D.S.; Henderson, S.A.; Croom-Carter, D.; Rowe, M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995, 10, 549-560.
74. Farrell, P.J. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol. 1998, 6, 175-177. discussion 177-178.
75. Pai, P.C.; Tseng, C.K.; Chuang, C.C.; Wei, K.C.; Hao, S.P.; Hsueh, C.; Chang, K.P.; Tsang, N.M. Polymorphism of C-terminal activation region 2 of Epstein-Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma. Head Neck 2007, 29, 109-119.
76. Vaysberg, M.; Hatton, O.; Lambert, S.L.; Snow, A.L.; Wong, B.; Krams, S.M.; Martinez, O.M. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. J. Biol. Chem. 2008, 283, 36573-36585.
77. Correa, R.M.; Fellner, M.D.; Alonio, L.V.; Durand, K.; Teyssie, A.R.; Picconi, M.A. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J. Med. Virol. 2004, 73, 583-588.
78. Cheung, S.T.; Leung, S.F.; Lo, K.W.; Chiu, K.W.; Tam, J.S.; Fok, T.F.; Johnson, P.J.; Lee, J.C.; Huang, D.P. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer 1998, 76, 399-406.
79. Hayashi, K.; Chen, W.G.; Chen, Y.Y.; Murakami, I.; Chen, H.L.; Ohara, N.; Nose, S.; Hamaya, K.; Matsui, S.; Bacchi, M.M., et al. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes. Am. J. Pathol. 1998, 152, 191-198.
80. Zhang, X.S.; Song, K.H.; Mai, H.Q.; Jia, W.H.; Feng, B.J.; Xia, J.C.; Zhang, R.H.; Huang, L.X.; Yu, X.J.; Feng, Q.S., et al. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett. 2002, 176, 65-73.
81. Tai, Y.C.; Kim, L.H.; Peh, S.C. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract. Pathol. Int. 2004, 54, 158-166.
82. Jen, K.Y.; Higuchi, M.; Cheng, J.; Li, J.; Wu, L.Y.; Li, Y.F.; Lin, H.L.; Chen, Z.; Gurtsevitch, V.; Fujii, M., et al. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas. Virus Genes 2005, 30, 223-235.
83. Chang, K.P.; Hao, S.P.; Lin, S.Y.; Ueng, S.H.; Pai, P.C.; Tseng, C.K.; Hsueh, C.; Hsieh, M.S.; Yu, J.S.; Tsang, N.M. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Laryngoscope 2006, 116, 541-546.
84. Correa, R.M.; Fellner, M.D.; Durand, K.; Redini, L.; Alonio, V.; Yampolsky, C.; Colobraro, A.; Sevlever, G.; Teyssie, A.; Benetucci, J., et al. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients. J. Med. Virol. 2007, 79, 401-407.
85. See, H.S.; Yap, Y.Y.; Yip, W.K.; Seow, H.F. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J. Surg. Oncol. 2008, 6, 18.
86. Lorenzetti, M.A.; Gantuz, M.; Altcheh, J.; De Matteo, E.; Chabay, P.A.; Preciado, M.V. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. J. Clin. Microbiol. 2012, 50, 609-618.
87. Banko, A.; Lazarevic, I.; Cupic, M.; Stevanovic, G.; Boricic, I.; Jovanovic, T. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients. J. Med. Virol. 2012, 84, 632-642.
88. Hadhri-Guiga, B.; Khabir, A.M.; Mokdad-Gargouri, R.; Ghorbel, A.M.; Drira, M.; Daoud, J.; Frikha, M.; Jlidi, R.; Gargouri, A. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients. Virus Res. 2006, 115, 24-30.
89. Larcher, C.; Bernhard, D.; Schaadt, E.; Adler, B.; Ausserlechner, M.J.; Mitterer, M.; Huemer, H.P. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants. Haematologica 2003, 88, 1324-1335.
90. Chen, J.N.; Ding, Y.G.; Feng, Z.Y.; Li, H.G.; He, D.; Du, H.; Wu, B.; Shao, C.K. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. J. Med. Virol. 2010, 82, 658-667.
91. Chen, J.N.; Jiang, Y.; Li, H.G.; Ding, Y.G.; Fan, X.J.; Xiao, L.; Han, J.; Du, H.; Shao, C.K. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res. 2011, 160, 191-199.
92. BenAyed-Guerfali, D.; Ayadi, W.; Miladi-Abdennadher, I.; Khabir, A.; Sellami-Boudawara, T.; Gargouri, A.; Mokdad-Gargouri, R. Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia. Virol. J. 2011, 8, 500.
93. Higa, M.; Kinjo, T.; Kamiyama, K.; Iwamasa, T.; Hamada, T.; Iyama, K. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. J. Clin. Pathol. 2002, 55, 414-423.
94. Corvalan, A.; Ding, S.; Koriyama, C.; Carrascal, E.; Carrasquilla, G.; Backhouse, C.; Urzua, L.; Argandona, J.; Palma, M.; Eizuru, Y., et al. Association of a distinctive strain of Epstein-Barr virus with gastric cancer. Int. J. Cancer 2006, 118, 1736-1742.
95. Busson, P.; Edwards, R.H.; Tursz, T.; Raab-Traub, N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 1995, 76(Pt 1), 139-145.
96. Berger, C.; Rothenberger, S.; Bachmann, E.; McQuain, C.; Nadal, D.; Knecht, H. Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations. Int. J. Cancer 1999, 81, 371-375.
97. Tanaka, M.; Kawaguchi, Y.; Yokofujita, J.; Takagi, M.; Eishi, Y.; Hirai, K. Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes 1999, 19, 103-111.
98. Wang, X.; Liu, X.; Jia, Y.; Chao, Y.; Xing, X.; Wang, Y.; Luo, B. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. J. Gen. Virol. 2010, 91, 2564-2573.
99. Han, J.; Chen, J.N.; Zhang, Z.G.; Li, H.G.; Ding, Y.G.; Du, H.; Shao, C.K. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 2012, 7, e34276.
100. Lee, S.P.; Thomas, W.A.; Murray, R.J.; Khanim, F.; Kaur, S.; Young, L.S.; Rowe, M.; Kurilla, M.; Rickinson, A.B. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 1993, 67, 7428-7435.
101. Rickinson, A.B.; Moss, D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 1997, 15, 405-431.
102. Khanna, R.; Moss, D.J.; Burrows, S.R. Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation. Immunol. Rev. 1999, 170, 49-64.
103. Bhatia, K.; Raj, A.; Guitierrez, M.I.; Judde, J.G.; Spangler, G.; Venkatesh, H.; Magrath, I.T. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 1996, 13, 177-181.
104. Habeshaw, G.; Yao, Q.Y.; Bell, A.I.; Morton, D.; Rickinson, A.B. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J. Virol. 1999, 73, 965-975.
105. Wrightham, M.N.; Stewart, J.P.; Janjua, N.J.; Pepper, S.D.; Sample, C.; Rooney, C.M.; Arrand, J.R. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 1995, 208, 521-530.
106. Chen, M.R.; Tsai, C.H.; Wu, F.F.; Kan, S.H.; Yang, C.S.; Chen, J.Y. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. J. Gen. Virol. 1999, 80(Pt 2), 447-455.
107. Bell, M.J.; Brennan, R.; Miles, J.J.; Moss, D.J.; Burrows, J.M.; Burrows, S.R. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J. Infect. Dis. 2008, 197, 1594-1597.
108. Ai, J.; Xie, Z.; Liu, C.; Huang, Z.; Xu, J. Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Virol. J. 2012, 9, 13.
109. Snudden, D.K.; Smith, P.R.; Lai, D.; Ng, M.H.; Griffin, B.E. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 1995, 10, 1545-1552.
110. Zhang, X.S.; Wang, H.H.; Hu, L.F.; Li, A.; Zhang, R.H.; Mai, H.Q.; Xia, J.C.; Chen, L.Z.; Zeng, Y.X. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett. 2004, 211, 11-18.
111. Wang, Y.; Liu, X.; Xing, X.; Cui, Y.; Zhao, C.; Luo, B. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res. 2010, 147, 258-264.
112. Do, N.V.; Ingemar, E.; Phi, P.T.; Jenny, A.; Chinh, T.T.; Zeng, Y.; Hu, L. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res. 2008, 132, 15-24.
113. Mai, S.J.; Xie, D.; Huang, Y.F.; Wang, F.W.; Liao, Y.J.; Deng, H.X.; Liu, W.J.; Hua, W.F.; Zeng, Y.X. The enhanced transcriptional activity of the V-val subtype of Epstein-Barr virus nuclear antigen 1 in epithelial cell lines. Oncol. Rep. 2010, 23, 1417-1424.
114. Crawford, D.H.; Macsween, K.F.; Higgins, C.D.; Thomas, R.; McAulay, K.; Williams, H.; Harrison, N.; Reid, S.; Conacher, M.; Douglas, J., et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin. Infect. Dis. 2006, 43, 276-282.
115. Lay, M.L.; Lucas, R.M.; Toi, C.; Ratnamohan, M.; Ponsonby, A.L.; Dwyer, D.E. Epstein-Barr Virus Genotypes and Strains in Central Nervous System Demyelinating Disease and Epstein-Barr Virus-Related Illnesses in Australia. Intervirology 2012, 55, 372-379
116. Wang, X.; Wang, Y.; Wu, G.; Chao, Y.; Sun, Z.; Luo, B. Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas. Virol. J. 2012, 9, 49.
117. Gorzer, I.; Niesters, H.G.; Cornelissen, J.J.; Puchhammer-Stockl, E. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus. Res. 2006, 118, 105-114.
118. Wu, G.; Wang, Y.; Chao, Y.; Jia, Y.; Zhao, C.; Luo, B. Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China. Arch. Virol. 2012, 157, 845-853.
119. Chu, P.G.; Chang, K.L.; Chen, W.G.; Chen, Y.Y.; Shibata, D.; Hayashi, K.; Bacchi, C.; Bacchi, M.; Weiss, L.M. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations. Am. J. Pathol. 1999, 155, 941-947.
120. Arrand, J.R.; Young, L.S.; Tugwood, J.D. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J. Virol. 1989, 63, 983-986.
121. Wang, Y.; Zhang, X.; Chao, Y.; Jia, Y.; Xing, X.; Luo, B. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. J. Med. Virol. 2010, 82, 829-836.
122. Li, A.; Zhang, X.S.; Jiang, J.H.; Wang, H.H.; Liu, X.Q.; Pan, Z.G.; Zeng, Y.X. Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential. Cell Cycle 2005, 4, 304-309.
123. Wang, F.W.; Wu, X.R.; Liu, W.J.; Liang, Y.J.; Huang, Y.F.; Liao, Y.J.; Shao, C.K.; Zong, Y.S.; Mai, S.J.; Xie, D. The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro. Eur. Arch. Otorhinolaryngol. 2012, 269, 931-938.
124. Tierney, R.J.; Kao, K.Y.; Nagra, J.K.; Rickinson, A.B. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. J. Virol. 2011, 85, 12362-12375.
125. Lorenzetti, M.A.; Gutierrez, M.I.; Altcheh, J.; Moscatelli, G.; Moroni, S.; Chabay, P.A.; Preciado, M.V. Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas. J. Med. Virol. 2009, 81, 1912-1917.
126. Jin, Y.; Xie, Z.; Lu, G.; Yang, S.; Shen, K. Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children. Virol. J. 2010, 7, 92.
127. Imajoh, M.; Hashida, Y.; Murakami, M.; Maeda, A.; Sato, T.; Fujieda, M.; Wakiguchi, H.; Daibata, M. Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis. J. Med. Virol. 2012, 84, 940-946.
128. Martini, M.; Capello, D.; Serraino, D.; Navarra, A.; Pierconti, F.; Cenci, T.; Gaidano, G.; Larocca, L.M. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J. Infect. 2007, 54, 298-306.
129. Ji, K.M.; Li, C.L.; Meng, G.; Han, A.D.; Wu, X.L. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China. Arch. Virol. 2008, 153, 1949-1953.
130. Luo, B.; Tang, X.; Jia, Y.; Wang, Y.; Chao, Y.; Zhao, C. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China. Microbes Infect. 2011, 13, 776-782.
131. Hicks, M.R.; Balesaria, S.; Medina-Palazon, C.; Pandya, M.J.; Woolfson, D.N.; Sinclair, A.J. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J. Virol. 2001, 75, 5381-5384.
132. Jia, Y.; Wang, Y.; Chao, Y.; Jing, Y.; Sun, Z.; Luo, B. Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas. Virol. J. 2010, 7, 341.
133. Jing, Y.Z.; Wang, Y.; Jia, Y.P.; Luo, B. Polymorphisms of Epstein-Barr virus BHRF1 gene, a homologue of bcl-2. Chin. J. Cancer 2010, 29, 1000-1005.
134. Horst, D.; Burrows, S.R.; Gatherer, D.; van Wilgenburg, B.; Bell, M.J.; Boer, I.G.; Ressing, M.E.; Wiertz, E.J. Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation. J. Virol. 2012, 86, 572-577.
135. Khanim, F.; Dawson, C.; Meseda, C.A.; Dawson, J.; Mackett, M.; Young, L.S. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J. Gen. Virol. 1997, 78(Pt 11), 2987-2999.
136. Strockbine, L.D.; Cohen, J.I.; Farrah, T.; Lyman, S.D.; Wagener, F.; DuBose, R.F.; Armitage, R.J.; Spriggs, M.K. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 1998, 72, 4015-4021.
137. Hutajulu, S.H.; Hoebe, E.K.; Verkuijlen, S.A.; Fachiroh, J.; Hariwijanto, B.; Haryana, S.M.; Stevens, S.J.; Greijer, A.E.; Middeldorp, J.M. Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infect. Agent Cancer 2010, 5, 16.
138. Wang, Y.; Wang, X.F.; Sun, Z.F.; Luo, B. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies. Virus Res. 2012, 166, 23-30.
139. Kawaguchi, A.; Kanai, K.; Satoh, Y.; Touge, C.; Nagata, K.; Sairenji, T.; Inoue, Y. The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene. Virus Genes 2009, 38, 215-223.
140. Luo, B.; Liu, M.; Chao, Y.; Wang, Y.; Jing, Y.; Sun, Z. Characterization of Epstein-Barr virus gp350/220 gene variants in virus isolates from gastric carcinoma and nasopharyngeal carcinoma. Arch. Virol. 2012, 157, 207-216.
141. Cohen, J.I.; Wang, F.; Mannick, J.; Kieff, E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 1989, 86, 9558-9562.
142. Sample, J.; Young, L.; Martin, B.; Chatman, T.; Kieff, E.; Rickinson, A. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 1990, 64, 4084-4092.
143. Tomkinson, B.; Kieff, E. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection. J. Virol. 1992, 66, 780-789.
144. Rowe, M.; Young, L.S.; Crocker, J.; Stokes, H.; Henderson, S.; Rickinson, A.B. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 1991, 173, 147-158.
145. Cohen, J.I.; Picchio, G.R.; Mosier, D.E. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J, Virol, 1992, 66, 7555-7559.
146. Lucchesi, W.; Brady, G.; Dittrich-Breiholz, O.; Kracht, M.; Russ, R.; Farrell, P.J. Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. J, Virol, 2008, 82, 7456-7466.
147. Cancian, L.; Bosshard, R.; Lucchesi, W.; Karstegl, C.E.; Farrell, P.J. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. PLoS Pathog. 2011, 7, e1002164.